Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report issued on Tuesday.
Several other research analysts have also recently weighed in on TCMD. BTIG Research cut shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th. Oppenheimer downgraded Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 5th. Finally, B. Riley assumed coverage on shares of Tactile Systems Technology in a research report on Thursday, September 26th. They issued a “buy” rating and a $23.00 price target on the stock.
Check Out Our Latest Report on TCMD
Tactile Systems Technology Trading Up 0.7 %
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Arcadia Investment Management Corp MI bought a new position in shares of Tactile Systems Technology during the 3rd quarter valued at about $29,000. Gladius Capital Management LP acquired a new stake in Tactile Systems Technology during the 3rd quarter worth approximately $44,000. Quarry LP bought a new position in Tactile Systems Technology in the second quarter valued at approximately $46,000. Magnetar Financial LLC acquired a new position in shares of Tactile Systems Technology in the second quarter valued at approximately $130,000. Finally, SG Americas Securities LLC bought a new stake in shares of Tactile Systems Technology during the third quarter worth $156,000. 83.43% of the stock is owned by institutional investors and hedge funds.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Further Reading
- Five stocks we like better than Tactile Systems Technology
- Investing in the High PE Growth Stocks
- Tesla Poised to Hit Record Highs This Holiday Season
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The Salesforce Rally is Just Getting Started: Here’s Why
- What is the Euro STOXX 50 Index?
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.